semaglutide benefits beyond weight loss New Wegovy clinical trial finds surprising that go way GLP-1 medications may offer benefits

Long-term data from the SEQUEL extension study followed Qsymia participants for an additional year, demonstrating maintained weight loss of 9.3% at 108 weeks

The impact of medication on vitamin D status in older individuals

Ginkgo biloba attenuates oxidative stress in macrophages and endothelial cells

However, insurance coverage frequently remains a barrier for the nondiabetes indications for GLP-1 agonists. Wegovy Reduced Liver Inflammation, Fat Accumulation, and Scarring For the new study, researchers followed 800 people with MASH and moderate to advanced liver fibrosis

Can BPC-157 Be Used With Other Therapies